Goldman Sachs’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Sell |
|
|||||
|
2025
Q1 | $2.79M | Buy |
|
|||||
|
2024
Q4 | $2.23M | Sell |
|
|||||
|
2024
Q3 | $5.52M | Buy |
|
|||||
|
2024
Q2 | $4.34M | Sell |
|
|||||
|
2024
Q1 | $4.95M | Buy |
|
|||||
|
2023
Q4 | $4.43M | Buy |
|
|||||
|
2023
Q3 | $1.16M | Buy |
|
|||||
|
2023
Q2 | $334K | Sell |
|
|||||
|
2023
Q1 | $142K | Buy |
|
|||||
|
2022
Q4 | $78.4K | Sell |
|
|||||
|
2022
Q3 | $522K | Sell |
|
|||||
|
2022
Q2 | $835K | Sell |
|
|||||
|
2022
Q1 | $1.9M | Buy |
|
|||||
|
2021
Q4 | $2.04M | Buy |
|
|||||
|
2021
Q3 | $4.15M | Buy |
|
|||||
|
2021
Q2 | $1.37M | Buy |
|
|||||
|
2021
Q1 | $700K | Sell |
|
|||||
|
2020
Q4 | $2.65M | Buy |
|